|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 254.25 USD | +0.89% |
|
-0.68% | +11.18% |
| 15/07 | RBC Upgrades ResMed to Outperform From Sector Perform, Adjusts Price Target to $294 From $255 | MT |
| 09/07 | Resmed Insider Sold Shares Worth $2,056,076, According to a Recent SEC Filing | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RESMED, INC. | Other Advanced Medical Equipment & Technology | +0.89% | -0.68% | +11.18% | +22.94% | +29.84% | 3.72TCr |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- RMD Stock
- Charts ResMed, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition